Characterization of a unique ADP-ribosyltransferase of Mycoplasma penetrans

Coreen Johnson1, T R Kannan, Joel B Baseman

  • 1Department of Microbiology and Immunology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, MC 7758, San Antonio, TX 78229-3900, USA.

Infection and Immunity
|August 5, 2009
PubMed

Insights

Mycoplasma penetrans harbors a novel toxin, MYPE9110, that damages host cells by ADP-ribosylation and NAD hydrolysis. This protein contributes to immune system decline in AIDS patients.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Immunology

Background:

  • Mycoplasma penetrans is a urogenital pathogen linked to immune deterioration in AIDS patients.
  • ADP-ribosyltransferases (ADPRTs) are toxins that modify host proteins, impacting cellular functions.

Purpose of the Study:

  • To characterize a novel 78-kDa protein, MYPE9110, from M. penetrans.
  • To investigate the enzymatic activities and cellular effects of MYPE9110.

Main Methods:

  • Sequence analysis to identify conserved ADPRT motifs.
  • In vitro assays to assess ADP-ribosylation and NAD-glycohydrolase activities.
  • Cell-based assays using HeLa cells to observe cytopathology and protein binding.

Main Results:

  • MYPE9110 shares sequence similarity with known bacterial ADPRTs and possesses essential catalytic residues.
  • The protein ADP-ribosylates mammalian proteins and exhibits auto-ADP-ribosylation and NAD-glycohydrolase activity.
  • MYPE9110 induces cytoplasmic vacuolization in HeLa cells; C-terminal deletion affects host cell binding but not enzymatic activity.

Conclusions:

  • MYPE9110 is a novel A-B ADPRT toxin from Mycoplasma penetrans.
  • This toxin contributes to the pathogenesis of M. penetrans, potentially exacerbating immune decline in HIV-infected individuals.
  • MYPE9110 represents a new target for understanding and potentially counteracting Mycoplasma-associated diseases.